Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

Technology company Philips plans to cut an estimated 5% of its workforce, about 4,000 positions, due to losses caused by the recall of a sleep apnea product as well as supply chain issues, according ...

Phillips Respironics has updated its usage instructions for three of its BiPAP ventilator models after reports of therapy interruptions and device failures that could result in serious injury or death ...

PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is ...

Eight deaths and 13 injuries have been associated with a class I recall of Philips Respironics’ BiPAP ventilators. FDA noted that the devices may unexpectedly reboot or enter an interoperative state.

Medical device manufacturer Philips announced the company will expand on a previous recall in an ongoing effort to remove equipment that could have a contaminant in one of the plastic components.